Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 5/20 | 0.43 |
| ▸ | UTS2R | Q9UKP6 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | TPH1 | P17752 | 5/20 | 0.33 |
| ▸ | FCER2 | P06734 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6316601 | 0.85 | GHSR (0.52) | GHSRFCER2 | |
| SCHEMBL6325174 | 0.85 | GHSR (0.52) | GHSRFCER2 | |
| SCHEMBL6325178 | 0.85 | GHSR (0.52) | GHSRFCER2 | |
| SCHEMBL6316607 | 0.85 | GHSR (0.52) | GHSRFCER2 | |
| SCHEMBL7161809 | 0.75 | GHSR (0.48) | GHSRUTS2R | |
| SCHEMBL6319375 | 0.74 | GHSR (0.51) | GHSRFCER2 | |
| SCHEMBL6318441 | 0.74 | GHSR (0.51) | GHSRFCER2 | |
| SCHEMBL6319367 | 0.74 | GHSR (0.51) | GHSRFCER2 | |
| SCHEMBL8100511 | 0.71 | MC4R (0.50) | GHSRFCER2 | |
| SCHEMBL6318997 | 0.70 | GHSR (0.48) | GHSRFCER2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6555570-B2 | Growth hormone secretagogous with improved bioavailability | NOVO NORDISK A/S (DE) | 2003-04-29 | — | — | US | disclosed |